Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Notch Therapeutics has raised $15.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Notch Therapeutics's investors include Samsara BioCapital, Lumira Ventures, Creative Destruction Lab, Casdin Capital, EcoR1 Capital.
Notch Therapeutics is headquartered in Toronto, Canada.
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Notch Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Notch Therapeutics — Funding & Investors." VCBacked, June 14, 2024, https://www.vcbacked.co/company/notch-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Notch Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/notch-therapeutics
{{cite web |title=Notch Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/notch-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated